TOP TIERMARKET NEWSWIRE
News & sentiment

TAYSHA GENE THERAPIE (TSHA) — News & AI sentiment

TAYSHA GENE THERAPIE (TSHA) news roundup. 3 stories in the past week, 7 over 30 days. Average 30-day sentiment is 58.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $1.2M — net selling of $1.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 59.7/100
30d stories
7
avg sentiment 58.3/100
Insider net (90d)
$1.2M
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

TSHA news in the last 24 hours, 7 days, 30 days and 90 days

How much TSHA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTSHA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days359.7/100TSHA headlines →
Last 30 days758.3/100TSHA headlines →
Last 90 days3351.3/100TSHA headlines →

Latest stories on TSHA

2d ago
6d ago
6d ago
Sep 4
Sep 4
Aug 24
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call
The Motley Fool73 · bullishearnings
Aug 18
Why is Taysha Gene Therapies stock sliding today?
Investing.com Markets34 · bearishgeneral
Aug 12
Aug 12
Aug 12
Aug 11
Aug 11
Aug 11
Aug 11
Aug 11
Taysha Gene Therapies Q2 2026 Earnings Preview
Seeking Alpha34 · bearishearnings
Aug 10
Aug 7
Aug 4
Aug 3
Jul 15
Jul 12
Jul 12
Jun 30
Jun 25
Jun 25
Open TSHA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →